ARTICLE | Clinical News
Bexxar tositumomab radiolabeled monoclonal antibody regulatory update
February 7, 2000 8:00 AM UTC
CLTR received U.S. Patent No. 6,015,542 covering radiolabeled monoclonal antibodies that target the CD20 antigen on the surface of B cells to treat B cell lymphomas. ...